The potential population health impact of treating REDUCE-IT eligible US adults with Icosapent Ethyl

Por Catherine G. Derington, Adam P. Bress, Jennifer S. Herrick, Wenjun Fan, Nathan D. Wong, Katherine E. Andrade, Jonathan Johnson, Sephy Philip, David Abrahamson, Lixia Jiao, Deepak L. Bhatt, William S. Weintraub
Publicado em 2022-06-01

Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and COVID-19-related outcomes: A patient-level analysis of the PCORnet blood pressure control lab

Por Steven M. Smith, Raj A. Desai, Marta G. Walsh, Ester Kim Nilles, Katie Shaw, Myra Smith, Alanna M. Chamberlain, Catherine G. Derington, Adam P. Bress, Cynthia H. Chuang, Daniel E. Ford, Bradley W. Taylor, Sravani Chandaka, Lav Parshottambhai Patel, James McClay, Elisa Priest, Jyotsna Fuloria, Kruti Doshi, Faraz S. Ahmad, Anthony J. Viera, Madelaine Faulkner, Emily C. O'Brien, Mark J. Pletcher, Rhonda M. Cooper-DeHoff
Publicado em 2022-01-01